Important: Michigan Weight Loss Institute prescribes only FDA-approved, branded GLP-1 medications
Nicolas Verhoeven, PhD / Physionic References [1] Rosenstock J, Frias J, Jastreboff AM, et al
47 While lifestyle modifications, regular physical activity and diet are recommended for all HF patients, weight reduction should be a direct therapy goal for patients with HFpEF and obesity
Wegovy is an eligible expense for health savings accounts (HSA) and flexible spending accounts (FSA) when prescribed for chronic weight management with appropriate BMI criteria
When used according to label directions, Swanson L-Glutathione can be part of a balanced lifestyle focused on supporting the body's natural antioxidant defenses and overall well-being
In December 2025 , the WHO issued its first global guidelines recommending the use of GLP-1 drugs for treating obesity in adults, marking a major shift in international obesity management policy